期刊文献+

多因素干预治疗对2型糖尿病肾病Ⅳ期进展的影响:三年随访研究 被引量:1

The effect of multifactor intervention on the progression of type 2 diabetic nephropathy stage Ⅳ :a 3-year follow-up study
原文传递
导出
摘要 目的 评价多因素干预治疗对2型糖尿病肾病Ⅳ期进展的作用.方法 随机入选门诊2型糖尿病肾病Ⅳ期患者33例,根据简化的肾脏病膳食改良(MDRD)方程式计算出估算肾小球滤过率(eGFR),根据基线eGFR将患者分为eGFR ≥60 ml/(min·1.73 m2)组(A组,19例)和eGFR<60 ml/(min· 1.73 m2)组(B组,14例),收集一般资料、测定血液生化指标.两组同时进行多因素干预治疗,随访1,2,3年后分别复测上述指标.结果 3年随访期间,两组各指标均保持相对稳定,差异无统计学意义(P>0.05),其中A组eGFR呈进行性下降[分别为(91.6±18.0),(80.1±19.7),(78.4±16.2),(68.1±16.0) ml/(min·1.73 m2)],差异有统计学意义(P<0.01),而B组eGFR下降差异无统计学意义[分别为(52.8±4.7),(49.7±16.4),(48.5±11.4),(47.6±13.7) ml/(min· 1.73 m2)](P> 0.05);对两组各指标在随访1,2,3年时与基线值的差值进行组间比较,比较两组第3年与基线的差值时,B组eGFR的下降明显慢于A组[(5.23±1.40) ml/(min·1.73 m2)比(21.30±17.20) ml/(min·1.73 m2)],差异有统计学意义(P<0.01),余差异均无统计学意义(P>0.05).多元逐步回归分析显示白蛋白的变化与eGFR的下降相关.结论 多因素干预治疗能有效延缓2型糖尿病肾病Ⅳ期的进展,甚至相较eGFR≥60 ml/(min· 1.73 m2)患者,eGFR< 60 ml/(min· 1.73 m2)患者进展更加缓慢,并提示在多因素控制情况下,白蛋白的变化可能对eGFR的下降有影响. Objective To investigate the effect of multifactor intervention on the progression of type 2 diabetic nephropathy stage Ⅳ.Methods The study randomly recruited 33 patients with type 2 diabetic nephropathy stage Ⅳ.Estimated glomerular filtration rate (eGFR) was calculated according to the modified diet in renal disease (MDRD).According to the baseline eGFR,patients were divided into eGFR ≥60 ml/ (min· 1.73 m2) group (group A,19 cases) and eGFR 〈 60 ml/ (min· 1.73 m2) group (group B,14cases).Collected general information and determinated biochemical indexes.The two groups were treated with multifactor intervention,and all patients were tested again after treatment of 1,2,3 years.Results In 3-year of follow-up phase,all patients remained relatively stable,the level of biochemical indexes had no significant difference(P〉 0.05),except eGFR,which was significantly decreased in group A[(91.6 ± 18.0),(80.1 ± 19.7),(78.4 ± 16.2),(68.1 ± 16.0) ml/ (min· 1.73 m2)](P〈 0.01).The level of eGFR in group B decreased without significant significance [(52.8 ±4.7),(49.7 ±16.4),(48.5 ±11.4),(47.6 ±13.7) ml/ (min· 1.73 m2)] (P 〉 0.05).Compared the difference from baseline to that of the first,second and third year,there was no significant difference except eGFR in the third year,which decreased significantly slower in group B than that in group A[(5.23 ± 1.40) ml/(min· 1.73 m2) vs.(21.30 ± 17.20) ml/(min· 1.73 m2)](P 〈 0.01).The variation of albumin was associated with the decrease of eGFR by multiple stepwise regression.Conclusions Multifactor intervention can effectively delay the progression of type 2 diabetic nephropathy stage Ⅳ.Further more,the patients with eGFR 〈 60 ml/ (min· 1.73 m2) may move more slowly compared with eGFR60 ml/ (min· 1.73 m2) patients.The variation of albumin may influence the decrease of eGFR under multifactor intervention.
出处 《中国医师进修杂志》 2014年第7期12-17,共6页 Chinese Journal of Postgraduates of Medicine
基金 南京市医学科技发展项目(YKK10105) 江苏省科技发展计划(BK2010121)
关键词 糖尿病 2型 糖尿病肾病 干预性研究 Diabetes mellitus, type 2 Diabetic nephropathies Intervention studies
  • 相关文献

参考文献17

  • 1Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients : a 12 years observational study[J]. Indian J Med Res ,2012,136( 1 ) : 46-53.
  • 2Unsal A, Koc Y, Basturk T, et al. Risk factors for progression of renal disease in patient with diabetic nephropathy[ J ]. Eur Rev Med Pharmacol Sci, 2012,16(7 ) :878-883.
  • 3Heerspink H J, de Zeeuw D. The kidney in type 2 diabetes therapy [ J ]. Rev Diabet Stud, 2011,8 (3) : 392-402.
  • 4Chauveau P, Aparicio M. Benefits in nutritional interventions in patients with CKD stage 3-4[J ]. J Ren Nutr, 2011,21 (1):20-22.
  • 5Phisitkul K, Hegazy K, Chuahirun T,et al. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy[ J ]. Am J Med Sci, 2008,335 (4) : 284-291.
  • 6Kalantar-Zadeh K, Derose SF, Nicholas S,et al. Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus [ J ]. J Ren Nutr, 2009,19 ( 1 ) : 33-37.
  • 7Araki S, Nishio Y, Araki A, et al. Factors associated with progression of diabetic nephropathy in Japanese elderly patients with type 2 diabetes: sub-analysis of the Japanese Elderly Diabetes Intervention Trial [J]. Geriatr Gerontol Int, 2012, 12 Suppl 1: S127-133.
  • 8Saha SA, Turtle KR. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease [J]. Cardiol Clin, 2010,28 ( 3 ) : 497-516.
  • 9Uzu T, Kida Y, Yamauchi A,et al. The effects of blood pressure control levels on the renoprotection of type 2 diabetic patients without overt proteinuria [ J ]. J Am Soc Hypertens, 2012,6 (2) : 124-131.
  • 10王燕,赵霞,范斌,冯建萍,杨金奎.2型糖尿病血压控制与未来出现肾病终点的观察性研究[J].首都医科大学学报,2012,33(4):472-476. 被引量:7

二级参考文献31

  • 1管乐,郑少雄.2型糖尿病肾病危险因素[J].中华肾脏病杂志,2006,22(1):18-18. 被引量:12
  • 2史浩,陈楠,张文,任红,徐耀文,沈平雁,王伟铭,俞海瑾,李晓,冯晓蓓.简化MDRD公式预测慢性肾病患者肾小球滤过率的应用评价及校正[J].中国实用内科杂志,2006,26(5):665-669. 被引量:89
  • 3KDOQI.KDOQI Clinical Practice Guidelines and ClinicalPractice Recommendations for Diabetes and Chronic KidneyDisease.Am J Kidney Dis,2007;49(2Suppl 2):S12-S154.
  • 4Levey AS,Greene T,Sarnak MJ.Effect of dietary proteinrestriction on the progression of kidney disease:long-termfollow-up of the Modification of Diet in Renal Disease(MDRD)Study.Am J Kidney Dis,2006;48(6):879-888.
  • 5D’Amico G,Gentile MG,Fellin G,et al.Effect of dietaryprotein restriction on the progression of renal failure:aprospective randomized trial.Nephrol Dial Transplant,1994;9(11):1590-1594.
  • 6Eyre S,Attman PO,Haraldsson B,et al.Positive effects ofprotein restriction in patients with chronic kidney disease.JRen Nutr,2008;18(3):269-280.
  • 7Taes YE,Marescau B,De Vriese A,et al.Guanidinocompounds after creatine supplementation in renal failurepatients and their relation to inflammatory status.Nephrol DialTransplant,2008;23(4):1330-1335.
  • 8Chan JC,Malik V,Jia W,et al.Diabetes in Asia:epidemiology,risk factors,and pathophysiology.JAMA,2009;301(20):2129-2140.
  • 9Remuzzi G,Bertani T.Pathophysiology of progressivenephropathies.New Engl J Med,1998;339(20):1448-1456.
  • 10Chauveau P,Aparicio M.Benefits in nutritional interventions inpatients with CKD stage 3-4.J Ren Nutr,2011;21(1):20-22.

共引文献30

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部